Literature DB >> 20446815

Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.

Shibani Pati1, Aarif Y Khakoo, Jing Zhao, Fernando Jimenez, Michael H Gerber, Matthew Harting, John B Redell, Raymond Grill, Yoichi Matsuo, Sushovan Guha, Charles S Cox, Marvin S Reitz, John B Holcomb, Pramod K Dash.   

Abstract

The barrier formed by endothelial cells (ECs) plays an important role in tissue homeostasis by restricting passage of circulating molecules and inflammatory cells. Disruption of the endothelial barrier in pathologic conditions often leads to uncontrolled inflammation and tissue damage. An important component of this barrier is adherens junctions, which restrict paracellular permeability. The transmembrane protein vascular endothelial (VE)-cadherin and its cytoplasmic binding partner β-catenin are major components of functional adherens junctions. We show that mesenchymal stem cells (MSCs) significantly reduce endothelial permeability in cocultured human umbilical vascular endothelial cells (HUVECs) and following exposure to vascular endothelial growth factor, a potent barrier permeability-enhancing agent. When grown in cocultures with HUVECs, MSCs increased VE-cadherin levels and enhanced recruitment of both VE-cadherin and β-catenin to the plasma membrane. Enhanced membrane localization of β-catenin was associated with a decrease in β-catenin-driven gene transcription. Disruption of the VE-cadherin/β-catenin interaction by overexpressing a truncated VE-cadherin lacking the β-catenin interacting domain blocked the permeability-stabilizing effect of MSCs. Interestingly, a conditioned medium from HUVEC-MSC cocultures, but not from HUVEC or MSC cells cultured alone, significantly reduced endothelial permeability. In addition, intravenous administration of MSCs to brain-injured rodents reduced injury-induced enhanced blood-brain barrier permeability. Similar to the effect on in vitro cultures, this stabilizing effect on blood-brain barrier function was associated with increased expression of VE-cadherin. Taken together, these results identify a putative mechanism by which MSCs can modulate vascular EC permeability. Further, our results suggest that the mediator(s) of these vascular protective effects is a secreted factor(s) released as a result of direct MSC-EC interaction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20446815      PMCID: PMC3128758          DOI: 10.1089/scd.2010.0013

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  44 in total

1.  Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect.

Authors:  Uwe M Fischer; Matthew T Harting; Fernando Jimenez; Werner O Monzon-Posadas; Hasen Xue; Sean I Savitz; Glen A Laine; Charles S Cox
Journal:  Stem Cells Dev       Date:  2009-06       Impact factor: 3.272

Review 2.  Mesenchymal stem cells in health and disease.

Authors:  Antonio Uccelli; Lorenzo Moretta; Vito Pistoia
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

3.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

Authors:  O Tetsu; F McCormick
Journal:  Nature       Date:  1999-04-01       Impact factor: 49.962

4.  Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo.

Authors:  M Corada; M Mariotti; G Thurston; K Smith; R Kunkel; M Brockhaus; M G Lampugnani; I Martin-Padura; A Stoppacciaro; L Ruco; D M McDonald; P A Ward; E Dejana
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

5.  Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis.

Authors:  P Carmeliet; M G Lampugnani; L Moons; F Breviario; V Compernolle; F Bono; G Balconi; R Spagnuolo; B Oosthuyse; M Dewerchin; A Zanetti; A Angellilo; V Mattot; D Nuyens; E Lutgens; F Clotman; M C de Ruiter; A Gittenberger-de Groot; R Poelmann; F Lupu; J M Herbert; D Collen; E Dejana
Journal:  Cell       Date:  1999-07-23       Impact factor: 41.582

6.  Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions.

Authors:  P Andriopoulou; P Navarro; A Zanetti; M G Lampugnani; E Dejana
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-10       Impact factor: 8.311

Review 7.  TCF transcription factors: molecular switches in carcinogenesis.

Authors:  J Roose; H Clevers
Journal:  Biochim Biophys Acta       Date:  1999-10-29

8.  Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases.

Authors:  B Herren; B Levkau; E W Raines; R Ross
Journal:  Mol Biol Cell       Date:  1998-06       Impact factor: 4.138

9.  Vascular-endothelial-cadherin modulates endothelial monolayer permeability.

Authors:  P L Hordijk; E Anthony; F P Mul; R Rientsma; L C Oomen; D Roos
Journal:  J Cell Sci       Date:  1999-06       Impact factor: 5.285

10.  Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells.

Authors:  S Esser; M G Lampugnani; M Corada; E Dejana; W Risau
Journal:  J Cell Sci       Date:  1998-07       Impact factor: 5.285

View more
  48 in total

1.  Chromatographically isolated CD63+CD81+ extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBI.

Authors:  Dong-ki Kim; Hidetaka Nishida; Su Yeon An; Ashok K Shetty; Thomas J Bartosh; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

Review 2.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

3.  Stem cell-based therapies for multiple sclerosis: recent advances in animal models and human clinical trials.

Authors:  Sarah E Lutz; Justin Lengfeld; Dritan Agalliu
Journal:  Regen Med       Date:  2014-03       Impact factor: 3.806

4.  Matrix composition regulates three-dimensional network formation by endothelial cells and mesenchymal stem cells in collagen/fibrin materials.

Authors:  Rameshwar R Rao; Alexis W Peterson; Jacob Ceccarelli; Andrew J Putnam; Jan P Stegemann
Journal:  Angiogenesis       Date:  2012-03-02       Impact factor: 9.596

5.  Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-Cadherin/β-catenin signaling pathway.

Authors:  Tyler Menge; Michael Gerber; Kathryn Wataha; William Reid; Sushovan Guha; Charles S Cox; Pramod Dash; Marvin S Reitz; Aarif Y Khakoo; Shibani Pati
Journal:  Stem Cells Dev       Date:  2012-06-26       Impact factor: 3.272

6.  Transcriptional profiling reveals crosstalk between mesenchymal stem cells and endothelial cells promoting prevascularization by reciprocal mechanisms.

Authors:  Junxiang Li; Ying Ma; Ruifang Teng; Qian Guan; Jidong Lang; Jianhuo Fang; Haizhou Long; Geng Tian; Qiong Wu
Journal:  Stem Cells Dev       Date:  2014-11-25       Impact factor: 3.272

7.  Temporal studies into attachment, VE-cadherin perturbation, and paracellular migration of human umbilical mesenchymal stem cells across umbilical vein endothelial monolayers.

Authors:  Neven A Ebrahim; Lopa Leach
Journal:  Stem Cells Dev       Date:  2014-12-10       Impact factor: 3.272

8.  Response to cardiac regeneration validated.

Authors:  Anna V Naumova; Michel Modo; Anna Moore; Joseph A Frank; Charles E Murry
Journal:  Nat Biotechnol       Date:  2015-06       Impact factor: 54.908

9.  Far-red tracer analysis of traumatic cerebrovascular permeability.

Authors:  George P Liao; Scott D Olson; Daniel J Kota; Robert A Hetz; Philippa Smith; Supinder Bedi; Charles S Cox
Journal:  J Surg Res       Date:  2014-05-09       Impact factor: 2.192

10.  Clinical and mechanistic drivers of acute traumatic coagulopathy.

Authors:  Mitchell Jay Cohen; Matt Kutcher; Britt Redick; Mary Nelson; Mariah Call; M Margaret Knudson; Martin A Schreiber; Eileen M Bulger; Peter Muskat; Louis H Alarcon; John G Myers; Mohammad H Rahbar; Karen J Brasel; Herb A Phelan; Deborah J del Junco; Erin E Fox; Charles E Wade; John B Holcomb; Bryan A Cotton; Nena Matijevic
Journal:  J Trauma Acute Care Surg       Date:  2013-07       Impact factor: 3.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.